Telomir Pharmaceuticals Overview
Latest PEG ratio for Telomir Pharmaceuticals: 1.14 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow1.14
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for TELO is 1.14. That is below the sector sector average of 6.6. Investors often review this figure alongside Telomir Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, TELO currently prints 1.14 for PEG ratio, while the sector average sits near 6.6. That is roughly 82.7% below the sector mean. Large gaps often invite a closer look at Telomir Pharmaceuticals's growth, margins, and balance sheet.
A PEG ratio of 1.14 for Telomir Pharmaceuticals is not 'good' or 'bad' on its own. Compare it with the peer average (6.6) and with TELO's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting TELO's PEG ratio (1.14), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
